Babies born to women who have diabetes during pregnancy, either already existing or gestational, are at increased risk of low blood sugars after birth. This is because the babies have been exposed to higher than usual blood sugar (glucose) levels during the pregnancy and so have been producing relatively high levels of insulin. Some of these babies require additional breast milk, formula feeds or transfer to a special care nursery for intravenous fluids to correct the low blood sugar levels.
Some maternity care providers and women propose that expressing and storing colostrum, the initial nutrient-rich breast milk, during pregnancy, can be given to the baby if they develop low blood sugars after birth. This may help avoid the need for formula feeds if breastfeeding, intravenous fluids and separation from the mother if the baby has to go to the special care nursery. Although this process seems logical and is sometimes recommended, two small observational studies have shown that mothers who expressed breast milk during pregnancy were more likely to have their babies early and more of the babies were cared for in the special care nursery compared with those whose mothers did not express.
This systematic review sought to identify randomised controlled trials comparing outcomes for women with diabetes who were advised to express with women not advised to express and store breast milk during pregnancy. The search did not find any completed trials, although one trial is currently underway.
There is no high level evidence about the potential benefits and harms of the expression and storage of breast milk during pregnancy by women with diabetes.
Czytaj pełne streszczenie
Wprowadzenie
Some women with diabetes in pregnancy are encouraged to express and store colostrum prior to birthing. Following birth, the breastfed infant may be given the stored colostrum to minimise the use of artificial formula or intravenous dextrose administration if correction of hypoglycaemia is required. However, findings from observational studies suggest that antenatal breast milk expression may stimulate labour earlier than expected and increase admissions to special care nurseries for correction of neonatal hypoglycaemia.
Cele
To evaluate the benefits and harms of the expression and storage of breast milk during late pregnancy by women with diabetes.
Metody wyszukiwania badań
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 June 2014).
Kryteria doboru badań
All published and unpublished randomised controlled trials comparing antenatal breast milk expressing with not expressing, by pregnant women with diabetes (pre-existing or gestational) and a singleton pregnancy.
Zbieranie i analiza danych
Two review authors independently evaluated reports identified by the search strategy.
Główne wyniki
There were no published or unpublished randomised controlled trials comparing antenatal expressing with not expressing. One randomised trial is currently underway.
Wnioski autorów
There is no high level systematic evidence to inform the safety and efficacy of the practice of expressing and storing breast milk during pregnancy.
